Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-19T16:46:38.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T16:51:09.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The study record page now displays a 403 error, replacing detailed study content and links with an error state; users are presented with a 403 page instead of the study details.
    Difference
    20%
    Check dated 2026-09-21T20:48:13.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Publication entry added under Publications, listing a Lancet Oncology article related to ENGOT-OV43/GOG-3036/KEYLYNK-001; a note states that publications are automatically filled from PubMed.
    Difference
    0.1%
    Check dated 2026-09-14T17:33:43.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a new version of the page. This reflects an internal update/version control rather than a change to visible content.
    Difference
    0.0%
    Check dated 2026-08-31T18:15:26.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page shows updated Study Record Dates with new entries like 2026-08-19 and removal of older dates. These changes reflect maintenance of the record rather than modifications to the trial content or results.
    Difference
    0.1%
    Check dated 2026-08-24T21:32:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.